Epic Sciences
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
9381 Judicial Dr Ste 200, San Diego, Cal...Phone Number
(858) 356-6610Website
www.epicsciences.comRevenue
$33.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
3
1
1
About Epic Sciences
Epic Sciences Inc. develops diagnostic tests to molecularly characterize circulating tumor cells in the blood. Epic Sciences was founded in 2008 and is headquartered in San Diego.Explore more
Epic Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Epic Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Epic Sciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Epic Sciences recently announced quarterly report
Check if Epic Sciences has recently received funding, and reach out quickly before it becomes old news!
Epic Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Epic Sciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Epic Sciences
Product Launch: Get notified when Epic Sciences launches new products
Funding: Get notified immidiatlly once Epic Sciences has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Epic Sciences
Compare insights from companies similar to Epic Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Epic Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Epic Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Epic Sciences.
Epic Sciences financials insights
Gather financial insights about Epic Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series C
$30M
2015
Debt
$15M
2017
Series D
$40M
2018
Other Financing Round
$52M
2020
Debt
$1M
2022
Series F
$43M
2023
Series G
$24M
Epic Sciences Tech Stack
A closer look at the technologies used by Epic Sciences
Most Recent Scoops
Left Company
Executive Move
Mark Aguillard, Chief Commercial Officer, has left the organization and now serves as Chief Commercial Officer at DermTech.
Left Company
Executive Move
Left Company
Executive Move
Left Company
Executive Move
William Kullback, Chief Financial Officer (Short-Term Assignment), has left the organization.
Funding
Epic Sciences News & Media
Deerfield Management and Arsenal Capital Partners Lead $24M Series G For Epic Sciences
Epic Sciences, a San Diego, CA-based diagnostics company, raised $24M in Series G funding. The round, which brought the total... Read More The post Deerfield Management and Arsenal Capital Partners Lead $24M Series G For Epic Sciences appeared first on citybiz.Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC
SAN DIEGO--(BUSINESS WIRE)--Epic Sciences, Inc. (“Epic” or “Epic Sciences”), a privately held diagnostics company, has completed a $24 million Series G which together with its $43 million Series F financing, totals $67 million raised in the last twelve months. The company will use the capital from this additional round of private investment to fund the commercial infrastructure required to commercialize the three component tests of DefineMBC, which together provide a comprehensive blood-based bEPIC SCIENCES RAISES $42M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS
Funding will accelerate commercial launch of DefineMBC™ and expand Epic Sciences' liquid biopsy solutions for key global oncology trials SAN DIEGO, June 1, 2022 /PRNewswire/ -- Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43...EPIC SCIENCES' DefineMBC™ TEST DELIVERS COMPREHENSIVE LIQUID BIOPSY RESULTS FOR METASTATIC BREAST CANCER
20 US Clinical Cancer Centers, 16 Metastatic Breast Cancer Trials now powered by Epic Sciences platform DefineMBC™ assesses breast cancer as it evolves in later stages and new treatments become available SAN DIEGO, May 4, 2022 /PRNewswire/ -- Epic Sciences, Inc. has added DefineMBC™, a...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Epic Sciences
Sign Up For FreeTo access detailed company insights
Epic Sciences Inc. develops diagnostic tests to molecularly characterize circulating tumor cells in the blood. Epic Sciences was founded in 2008 and is headquartered in San Diego.... Read More
